Filing Details

Accession Number:
0001062993-22-021625
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-07 12:44:51
Reporting Period:
2022-11-03
Accepted Time:
2022-11-07 12:44:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
49071 Humana Inc HUM Hospital & Medical Service Plans (6324) 610647538
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1712481 Samir Deshpande Humana Inc.
500 W Main St
Louisville KY 40202
Chief Information Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Humana Common Acquisiton 2022-11-03 1,116 $268.47 6,645 No 4 M Direct
Humana Common Disposition 2022-11-03 535 $560.14 6,110 No 4 F Direct
Humana Common Acquisiton 2022-11-03 324 $307.97 6,434 No 4 M Direct
Humana Common Disposition 2022-11-03 179 $560.14 6,255 No 4 F Direct
Humana Common Acquisiton 2022-11-03 2,898 $268.47 9,153 No 4 M Direct
Humana Common Acquisiton 2022-11-03 5,064 $307.97 14,217 No 4 M Direct
Humana Common Disposition 2022-11-03 7,962 $565.95 6,255 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Humana Common Options Disposition 2022-11-03 4,014 $0.00 4,014 $268.47
Humana Common Options Disposition 2022-11-03 5,388 $0.00 5,388 $307.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-02-19 No 4 M Direct
0 2026-02-25 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Humana Common Options $350.79 2027-02-24 5,730 5,730 Direct
Humana Common Options $376.61 2028-02-22 4,327 4,327 Direct
Humana Common Options $425.06 2029-02-21 3,836 3,836 Direct
Humana Common Restricted Stock Units $0.00 380 380 Direct
Humana Common Restricted Stock Units $0.00 701 701 Direct
Humana Common Restricted Stock Units $0.00 1,059 1,059 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2027-02-24 5,730 5,730 Direct
2028-02-22 4,327 4,327 Direct
2029-02-21 3,836 3,836 Direct
380 380 Direct
701 701 Direct
1,059 1,059 Direct
Footnotes
  1. Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/2018, vesting in three increments from 2/19/19 to 2/19/21.
  2. Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/2019, vesting in three increments from 2/25/20 to 2/25/22.
  3. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
  4. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.
  5. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.
  6. Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
  7. Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.
  8. Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.
  9. Restricted stock units granted to reporting person on 02/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
  10. Shares reported were swapped for the purchase price of options exercised, using FMV on 11/2/2022. Shares were not sold or disposed of for value in return.
  11. Price reported is weighted average sales price.